Literature DB >> 28965250

A 5-year prospective study on regenerative periodontal therapy of infrabony defects using minimally invasive surgery and a collagen-enriched bovine-derived xenograft.

Thomas De Bruyckere1,2, Aryan Eghbali3, Faris Younes3, Roberto Cleymaet3, Wolfgang Jacquet3,4, Hugo De Bruyn4, Jan Cosyn3,4.   

Abstract

AIM: The primary objective of this study was (1) to evaluate the 5-year clinical outcome of regenerative periodontal therapy (RPT) using minimally invasive surgery and a collagen-enriched bovine-derived xenograft and (2) to identify predictors for clinical attachment level (CAL) gain and vertical radiographic bone (RB) gain.
MATERIALS AND METHODS: Ninety-five non-smoking patients with ≤ 25% full-mouth plaque and bleeding presenting ≥ 6 months after initial periodontal therapy with ≥ 1 isolated interdental infrabony defect were recruited. Minimally invasive surgery (MIST or M-MIST) and a collagen-enriched bovine-derived xenograft were used in all patients. Patients were surgically treated by the same clinician and evaluated up to 5 years of follow-up. Multivariate analyses were used to identify predictors for CAL gain and RB gain.
RESULTS: Before surgery, mean probing depth (PD) was 7.8 mm, CAL was 10.0 mm, and defect depth amounted to 5.2 mm. Seventy-one patients (33 men, 38 women, mean age 52) could be evaluated at 5 years. Mean PD reduction was 3.3 mm (SD 2.2), CAL gain was 3.0 mm (SD 2.1), and RB gain was 57% (SD 38). Forty-five percent showed ≥ 4 mm CAL gain, whereas 24% were considered failures (≤ 1 mm CAL gain). Forty-eight percent showed considerable RB gain (≥ 75%). Regression analyses showed that plaque was a significant predictor for CAL gain (p = 0.001) and RB gain (p = 0.005). Patients' compliance had a significant impact on RB gain (p < 0.001).
CONCLUSION: Only patients with perfect oral hygiene and excellent compliance should be considered for RPT. Especially, the latter can only be assessed after sufficient follow-up following initial periodontal therapy. CLINICAL RELEVANCE: RPT failed in 24% of the patients after 5 years. Regression analyses demonstrated a significant impact of plaque and patients' compliance on the long-term outcome. Only patients with perfect oral hygiene and excellent compliance should be considered for RPT. Patients should not be treated too soon following initial therapy, since compliance can only be reliably assessed after sufficient follow-up.

Entities:  

Keywords:  Infrabony defect; Minimally invasive surgery; Periodontal disease; Regeneration; Xenograft

Mesh:

Substances:

Year:  2017        PMID: 28965250     DOI: 10.1007/s00784-017-2208-x

Source DB:  PubMed          Journal:  Clin Oral Investig        ISSN: 1432-6981            Impact factor:   3.573


  44 in total

1.  Evaluation of periodontal regeneration following grafting intrabony defects with bio-oss collagen: a human histologic report.

Authors:  Marc L Nevins; Marcelo Camelo; Samuel E Lynch; Robert K Schenk; Myron Nevins
Journal:  Int J Periodontics Restorative Dent       Date:  2003-02       Impact factor: 1.840

2.  Reconstructive periodontal surgery: a challenge for modern periodontology.

Authors:  Pierpaolo Cortellini
Journal:  Int Dent J       Date:  2006-08       Impact factor: 2.512

3.  Three-dimensional micro-computed tomographic evaluation of periodontal regeneration: a human report of intrabony defects treated with Bio-Oss collagen.

Authors:  Marc L Nevins; Marcelo Camelo; Alberto Rebaudi; Samuel E Lynch; Myron Nevins
Journal:  Int J Periodontics Restorative Dent       Date:  2005-08       Impact factor: 1.840

4.  Open flap debridement and guided tissue regeneration after 10 years in infrabony defects.

Authors:  Katrin Nickles; Petra Ratka-Krüger; Eric Neukranz; Peter Raetzke; Peter Eickholz
Journal:  J Clin Periodontol       Date:  2009-10-06       Impact factor: 8.728

5.  The plaque control record.

Authors:  T J O'Leary; R B Drake; J E Naylor
Journal:  J Periodontol       Date:  1972-01       Impact factor: 6.993

6.  The angular bony defect as indicator of further alveolar bone loss.

Authors:  P N Papapanou; J L Wennström
Journal:  J Clin Periodontol       Date:  1991-05       Impact factor: 8.728

7.  Clinical and radiographic outcomes of the modified minimally invasive surgical technique with and without regenerative materials: a randomized-controlled trial in intra-bony defects.

Authors:  Pierpaolo Cortellini; Maurizio S Tonetti
Journal:  J Clin Periodontol       Date:  2011-02-08       Impact factor: 8.728

8.  Healing of human intrabony defects following regenerative periodontal therapy with a bovine-derived xenograft and guided tissue regeneration.

Authors:  A Sculean; A Stavropoulos; P Windisch; T Keglevich; T Karring; I Gera
Journal:  Clin Oral Investig       Date:  2004-02-06       Impact factor: 3.573

9.  Improved wound stability with a modified minimally invasive surgical technique in the regenerative treatment of isolated interdental intrabony defects.

Authors:  Pierpaolo Cortellini; Maurizio S Tonetti
Journal:  J Clin Periodontol       Date:  2009-02       Impact factor: 8.728

10.  The modified papilla preservation technique. A new surgical approach for interproximal regenerative procedures.

Authors:  P Cortellini; G P Prato; M S Tonetti
Journal:  J Periodontol       Date:  1995-04       Impact factor: 6.993

View more
  3 in total

1.  Modified minimally invasive surgical technique plus Bio-Oss Collagen for regenerative therapy of isolated interdental intrabony defects: study protocol for a randomised controlled trial.

Authors:  Churen Zhang; Haidong Zhang; Zhaoguo Yue; Lili Miao; Ye Han; Kaining Liu; Jianxia Hou
Journal:  BMJ Open       Date:  2020-12-10       Impact factor: 2.692

Review 2.  Minimally Invasive Periodontology: A Treatment Philosophy and Suggested Approach.

Authors:  Ethan Ng; John Rong Hao Tay; Marianne Meng Ann Ong
Journal:  Int J Dent       Date:  2021-06-22

3.  Human amniotic mesenchymal stromal cells promote bone regeneration via activating endogenous regeneration.

Authors:  Fei Jiang; Wenjie Zhang; Mingliang Zhou; Zhixuan Zhou; Ming Shen; Ning Chen; Xinquan Jiang
Journal:  Theranostics       Date:  2020-05-15       Impact factor: 11.556

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.